{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:22:12Z","timestamp":1774617732058,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T00:00:00Z","timestamp":1390262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s10067-014-2493-6","type":"journal-article","created":{"date-parts":[[2014,1,20]],"date-time":"2014-01-20T07:52:59Z","timestamp":1390204379000},"page":"391-395","source":"Crossref","is-referenced-by-count":24,"title":["Early-onset sarcoidosis caused by a rare CARD15\/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature"],"prefix":"10.1007","volume":"34","author":[{"given":"Francesco","family":"La Torre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Lapadula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orso Maria","family":"Lucherini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florenzo","family":"Iannone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,21]]},"reference":[{"key":"2493_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng720","volume":"29","author":"C Miceli-Richard","year":"2001","unstructured":"Miceli-Richard C, Lesage S, Rybojad M et al (2001) CARD15 mutations in Blau syndrome. Nat Genet 29:19\u201320","journal-title":"Nat Genet"},{"issue":"10","key":"2493_CR2","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/hmg\/5.10.1679","volume":"5","author":"JD Ohmen","year":"1996","unstructured":"Ohmen JD, Yang H-Y, Yamamoto KK et al (1996) Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn\u2019s disease, but not in ulcerative colitis. Hum Mol Genet 5(10):1679\u20131683","journal-title":"Hum Mol Genet"},{"key":"2493_CR3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0022-3476(85)80394-2","volume":"107","author":"EB Blau","year":"1985","unstructured":"Blau EB (1985) Familial granulomatous arthritis, iritis, and rash. J Pediat 107:689\u2013693","journal-title":"J Pediat"},{"issue":"1","key":"2493_CR4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.autrev.2012.07.028","volume":"12","author":"P Sfriso","year":"2012","unstructured":"Sfriso P, Caso F, Tognon S et al (2012) Blau syndrome, clinical, and genetic aspects. Autoimmun Rev 12(1):44\u201351","journal-title":"Autoimmun Rev"},{"key":"2493_CR5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/BOR.0b013e328349c430","volume":"23","author":"CD Ros\u00e9","year":"2011","unstructured":"Ros\u00e9 CD, Martin TM, Wouters CH (2011) Blau syndrome revisited. Curr Opin Rheumatol 23:411\u20138","journal-title":"Curr Opin Rheumatol"},{"key":"2493_CR6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-3476(05)81080-7","volume":"117","author":"GM Pastores","year":"1990","unstructured":"Pastores GM, Michels VV, Stickler GB et al (1990) Autosomal dominant granulomatous arthritis, uveitis, skin rash, and synovial cysts. J Pediatr 117:403\u2013408","journal-title":"J Pediatr"},{"key":"2493_CR7","first-page":"13","volume":"136","author":"S Hetherington","year":"1982","unstructured":"Hetherington S (1982) Sarcoidosis in young children. Am J Dis Child 136:13\u20135","journal-title":"Am J Dis Child"},{"key":"2493_CR8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0022-3476(86)80978-7","volume":"108","author":"EN Pattishall","year":"1986","unstructured":"Pattishall EN, Strope GL, Spinola SM et al (1986) Childhood sarcoidosis. Pediatrics 108:169\u2013177","journal-title":"Pediatrics"},{"issue":"2","key":"2493_CR9","first-page":"231","volume":"20","author":"R Cimaz","year":"2002","unstructured":"Cimaz R, Ansell BM (2002) Sarcoidosis in the pediatric age. Clin Exp Rheumatol 20(2):231\u2013237","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"2493_CR10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1651-2227.2004.tb00670.x","volume":"93","author":"AL Hoffmann","year":"2004","unstructured":"Hoffmann AL, Milman N, Byg KE (2004) Childhood sarcoidosis in Denmark 1979\u20131994: incidence, clinical features, and laboratory results at presentation in 48 children. Acta Paediatr Int J Paediatr 93(1):30\u201336","journal-title":"Acta Paediatr Int J Paediatr"},{"key":"2493_CR11","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/art.22122","volume":"54","author":"CD Ros\u00e9","year":"2006","unstructured":"Ros\u00e9 CD, Wouters CH, Meiorin S et al (2006) Pediatric granulomatous arthritis: an international registry. Arthritis Rheum 54:3337\u201344","journal-title":"Arthritis Rheum"},{"key":"2493_CR12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1440-0960.2005.00134.x","volume":"46","author":"G Masel","year":"2005","unstructured":"Masel G, Halbert A (2005) Blau syndrome presenting with ichthyosis. Australas J Dermatol 46:29\u201332","journal-title":"Australas J Dermatol"},{"issue":"12","key":"2493_CR13","first-page":"5","volume":"15","author":"DA Glass 2nd","year":"2009","unstructured":"Glass DA 2nd, Maender J, Metry D (2009) Two pediatric cases of Blau syndrome. Dermatol Online J 15(12):5","journal-title":"Dermatol Online J"},{"key":"2493_CR14","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/S0161-6420(03)00717-6","volume":"110","author":"T Kurokawa","year":"2003","unstructured":"Kurokawa T, Kikuchi T, Ohta K et al (2003) Ocular manifestations in Blau syndrome associated with a CARD15\/Nod2 mutation. Ophthalmology 110:2040\u20134","journal-title":"Ophthalmology"},{"issue":"2","key":"2493_CR15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaapos.2011.02.004","volume":"15","author":"VR Raiji","year":"2011","unstructured":"Raiji VR, Miller MM, Jung LK (2011) Uveitis in Blau syndrome from a de novo mutation of the NOD2\/CARD15 gene. Journal of AAPOS 15(2):205\u2013207","journal-title":"Journal of AAPOS"},{"issue":"6","key":"2493_CR16","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0002-9394(02)01709-9","volume":"134","author":"PA Latkany","year":"2002","unstructured":"Latkany PA, Jabs DA, Smith JR et al (2002) Multifocal choroiditis in patients with familial juvenile systemic granulomatosis. Am J Ophthalmol 134(6):897\u2013904","journal-title":"Am J Ophthalmol"},{"issue":"5\u20136","key":"2493_CR17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/08820538.2013.825285","volume":"28","author":"P Pillai","year":"2013","unstructured":"Pillai P, Sobrin L (2013) Blau syndrome-associated uveitis and the NOD2 gene. Semin Ophthalmol 28(5\u20136):327\u201332","journal-title":"Semin Ophthalmol"},{"key":"2493_CR18","first-page":"396","volume":"23","author":"SK Saini","year":"1996","unstructured":"Saini SK, Rose CD (1996) Liver involvement in familial granulomatous arthritis (Blau syndrome). J Rheumatol 23:396\u20139","journal-title":"J Rheumatol"},{"key":"2493_CR19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0022-3476(98)70286-0","volume":"133","author":"SS Ting","year":"1998","unstructured":"Ting SS, Ziegler J, Fischer E (1998) Familial granulomatous arthritis (Blau syndrome) with granulomatous renal lesions. J Pediatr 133:450\u20132","journal-title":"J Pediatr"},{"key":"2493_CR20","first-page":"2504","volume":"34","author":"A Emaminia","year":"2007","unstructured":"Emaminia A, Nabavi M, Mousavi Nasab M, Kashef S (2007) Central nervous system involvement in Blau syndrome: a new feature of the syndrome? J Rheumatol 34:2504\u20135","journal-title":"J Rheumatol"},{"key":"2493_CR21","first-page":"635","volume":"18","author":"V Dhondt","year":"2008","unstructured":"Dhondt V, Hofman S, Dahan K, Beele H (2008) Leg ulcers: a new symptom of Blau syndrome? Eur J Dermatol 18:635\u20137","journal-title":"Eur J Dermatol"},{"key":"2493_CR22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1749-8090-5-16","volume":"5","author":"F Mourad","year":"2010","unstructured":"Mourad F, Tang A (2010) Sinus of valsalva aneurysm in Blau\u2019s syndrome. J Cardiothorac Surg 5:16","journal-title":"J Cardiothorac Surg"},{"key":"2493_CR23","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1182\/blood-2004-07-2972","volume":"105","author":"N Kanazawa","year":"2005","unstructured":"Kanazawa N, Okafuji I, Kambe N et al (2005) Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor kappa B activation: common genetic etiology with Blau syndrome. Blood 105:1195\u20137","journal-title":"Blood"},{"key":"2493_CR24","first-page":"373","volume":"32","author":"CD Ros\u00e9","year":"2005","unstructured":"Ros\u00e9 CD, Doyle TM, McIlvain-Simpson G et al (2005) Blau syndrome mutation of CARD15\/NOD2 in sporadic early onset granulomatous arthritis. J Rheumatol 32:373\u20135","journal-title":"J Rheumatol"},{"issue":"3","key":"2493_CR25","first-page":"228","volume":"21","author":"R Priori","year":"2004","unstructured":"Priori R, Bombardieri M, Spinelli FR et al (2004) Sporadic Blau syndrome with a double CARD15 mutation. Report of a case with lifelong follow-up. Sarcoidosis Vasc Diffuse Lung Dis 21(3):228\u201331","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2493_CR26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3389\/fimmu.2013.00351","volume":"4","author":"S Federici","year":"2013","unstructured":"Federici S, Martini A, Gattorno M (2013) The central role of anti-IL-1 blockade in the treatment of monogenic and multifactorial autoinflammatory diseases. Front Immunol 4:351, Review","journal-title":"Front Immunol"},{"issue":"1","key":"2493_CR27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/art.24134","volume":"60","author":"I Okafuji","year":"2009","unstructured":"Okafuji I, Nishikomori R, Kanazawa N et al (2009) Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arthritis Rheum 60(1):242\u201350","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2493_CR28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.autrev.2008.07.034","volume":"8","author":"L Punzi","year":"2009","unstructured":"Punzi L, Furlan A, Podswiadek M et al (2009) Clinical and genetic aspects of Blau syndrome: a 25-year follow-up of one family and a literature review. Autoimmun Rev 8(3):228\u2013232","journal-title":"Autoimmun Rev"},{"issue":"3","key":"2493_CR29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/03009740802464194","volume":"38","author":"N Milman","year":"2009","unstructured":"Milman N, Ursin K, Rodevand E et al (2009) A novel mutation in the NOD2 gene associated with Blau syndrome a Norwegian family with four affected members. Scand J Rheumatol 38(3):190\u2013197","journal-title":"Scand J Rheumatol"},{"issue":"11","key":"2493_CR30","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1074\/jbc.C200651200","volume":"278","author":"SE Girardin","year":"2003","unstructured":"Girardin SE, Boneca IG, Viala J et al (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278(11):8869\u20138872","journal-title":"J Biol Chem"},{"issue":"7","key":"2493_CR31","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1074\/jbc.M008072200","volume":"276","author":"Y Ogura","year":"2001","unstructured":"Ogura Y, Inohara N, Benito A et al (2001) Nod2, a Nod1\/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 276(7):4812\u20138","journal-title":"J Biol Chem"},{"issue":"5","key":"2493_CR32","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1039\/b718948f","volume":"4","author":"TA Kufer","year":"2008","unstructured":"Kufer TA (2008) Signal transduction pathways used by NLR-type innate immune receptors. Mol Biosyst 4(5):380\u20136","journal-title":"Mol Biosyst"},{"issue":"6","key":"2493_CR33","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/sj.ejhg.5201404","volume":"13","author":"MM Duist Van","year":"2005","unstructured":"Van Duist MM, Albrecht M, Podswiadek M et al (2005) A new CARD15 mutation in Blau syndrome. Eur J Hum Genet 13(6):742\u20137","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"2493_CR34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/1753425910394002","volume":"18","author":"B Zurek","year":"2012","unstructured":"Zurek B, Proell M, Wagner RN et al (2012) Mutational analysis of human NOD1 and NOD2 NACHT domains reveals different modes of activation. Innate Immun 18(1):100\u201311","journal-title":"Innate Immun"},{"issue":"1","key":"2493_CR35","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jaad.2012.12.976","volume":"69","author":"N Kanazawa","year":"2013","unstructured":"Kanazawa N, Tchernev G, Kambe N (2013) Monogenic early-onset sarcoidosis is no longer a variant of idiopathic sarcoidosis. J Am Acad Dermatol 69(1):164\u20135","journal-title":"J Am Acad Dermatol"},{"key":"2493_CR36","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0002-9394(03)00892-4","volume":"136","author":"TM Martin","year":"2003","unstructured":"Martin TM, Doyle TM, Smith JR et al (2003) Uveitis in patients with sarcoidosis is not associated with mutations in NOD2 (CARD15). Am J Ophthalmol 136:933\u2013935","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"2493_CR37","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.berh.2011.10.017","volume":"25","author":"L Punzi","year":"2011","unstructured":"Punzi L, Gava A, Galozzi P, Sfriso P (2011) Miscellaneous non-inflammatory musculoskeletal conditions. Blau syndrome. Best Pract Res Clin Rheumatol 25(5):703\u201314","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"2493_CR38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0306-9877(03)00334-7","volume":"62","author":"EL Altschuler","year":"2004","unstructured":"Altschuler EL, Kast RE (2004) Bupropion for Blau syndrome. Med Hypothese 62(2):297\u2013298","journal-title":"Med Hypothese"},{"key":"2493_CR39","doi-asserted-by":"crossref","unstructured":"Vitale A, Rigante D, Lucherini OM et al. (2013) Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. Mediators Inflamm 2013:939847. Published online 2013 July 21","DOI":"10.1155\/2013\/939847"},{"issue":"12","key":"2493_CR40","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1600-0463.2006.apm_522.x","volume":"114","author":"N Milman","year":"2006","unstructured":"Milman N, Andersen CB, Hansen A et al (2006) Favorable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation. APMIS 114(12):912\u20139","journal-title":"APMIS"},{"issue":"4","key":"2493_CR41","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/art.22509","volume":"56","author":"ML Becker","year":"2007","unstructured":"Becker ML, Martin TM, Doyle TM, Rose CD (2007) Interstitial pneumonitis in Blau syndrome with documented mutation in CARD15. Arthritis Rheum 56(4):1292\u20134","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2493_CR42","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/rheumatology\/keq431","volume":"50","author":"SM Sharma","year":"2011","unstructured":"Sharma SM, Martin TM, Ros\u00e9 CD et al (2011) Distinguishing between the innate immune response due to ocular inflammation and infection in a child with juvenile systemic granulomatous disease treated with anti-TNF\u03b1 monoclonal antibodies. Rheumatology (Oxford) 50(5):990\u20132","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"2493_CR43","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00124743-200002000-00005","volume":"6","author":"IA Cuesta","year":"2000","unstructured":"Cuesta IA, Moore EC, Rabah R, Bawle EV (2000) Blau syndrome (familial granulomatous arthritis, iritis, and rash) in an African-American family. J Clin Rheumatol 6(1):30\u201334","journal-title":"J Clin Rheumatol"},{"key":"2493_CR44","first-page":"134106","volume":"2011","author":"F Caracseghi","year":"2011","unstructured":"Caracseghi F, Izquierdo-Blasco J, Sanchez-Montanez A et al (2011) Etanercept-induced myelopathy in a pediatric case of Blau syndrome. Case Rep Rheumatol 2011:134106","journal-title":"Case Rep Rheumatol"},{"key":"2493_CR45","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1002\/art.22966","volume":"56","author":"JI Ar\u00f3stegui","year":"2007","unstructured":"Ar\u00f3stegui JI, Arnal C, Merino R et al (2007) NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum 56:3805\u201313","journal-title":"Arthritis Rheum"},{"key":"2493_CR46","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/art.24222","volume":"60","author":"TM Martin","year":"2009","unstructured":"Martin TM, Zhang Z, Kurz P et al (2009) The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity. Arthritis Rheum 60:611\u2013618","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2493_CR47","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.37776","volume":"65","author":"G Simonini","year":"2013","unstructured":"Simonini G, Xu Z, Caputo R et al (2013) Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. Arthritis Rheum 65(2):513\u20138","journal-title":"Arthritis Rheum"},{"key":"2493_CR48","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/art.25035","volume":"62","author":"K Yasui","year":"2010","unstructured":"Yasui K, Yashiro M, Tsuge M et al (2010) Thalidomide dramatically improves the symptoms of early-onset sarcoidosis\/Blau syndrome: its possible action and mechanism. Arthritis Rheum 62:250\u2013257","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2493-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2493-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2493-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:31Z","timestamp":1559120251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2493-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,21]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["2493"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2493-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,21]]}}}